Literature DB >> 7789639

Microvascular function in human diabetes. A physiological perspective.

J E Tooke1.   

Abstract

The late complications of diabetes represent in large part microvascular dysfunction. The development of techniques to measure microvascular function has resulted in a clearer picture of the stages of development of microangiopathy and the key pathophysiological processes involved. Considerable evidence supports the hemodynamic hypothesis of pathogenesis, which argues that early insulin-dependent diabetes is characterized by increased microvascular pressure and flow. Resultant injury to the microvascular endothelium causes adaptive microvascular sclerosis contributing to a loss of vasodilatory reserve and autoregulatory capacity with increasing disease duration. High susceptibility to microangiopathy appears to be characterized by both high capillary pressure and increased permeability, although the interrelationship between these variables needs to be better defined. In normotensive non-insulin-dependent diabetes subjects, a different pattern of microvascular functional abnormalities is apparent; it is hypothesized that these differences represent the impact of a prediabetic insulin-resistant phase on microvascular behavior and may in part explain the differential expression of vascular pathology in the two major types of diabetes. The physiological framework that has been defined reveals those pivotal processes upon which scientific attention should be centered and facilitates the generation of plausible molecular and cellular mechanisms that fit the physiological facts.

Entities:  

Mesh:

Year:  1995        PMID: 7789639     DOI: 10.2337/diab.44.7.721

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  57 in total

1.  Sympathetic mediated vasomotion and skin capillary permeability in diabetic patients with peripheral neuropathy.

Authors:  J D Lefrandt; E Bosma; P H N Oomen; J H Hoeven; A M Roon; A J Smit; K Hoogenberg
Journal:  Diabetologia       Date:  2003-01-11       Impact factor: 10.122

2.  Histochemical analysis of lymphatic endothelial cells in the pancreas of non-obese diabetic mice.

Authors:  P Qu; R C Ji; S Kato
Journal:  J Anat       Date:  2003-11       Impact factor: 2.610

3.  Diabetic retinopathy and endothelial dysfunction in patients with type 2 diabetes mellitus.

Authors:  Jae-Seung Yun; Seung-Hyun Ko; Ji-Hoon Kim; Keon-Woong Moon; Kun-Woong Moon; Yong-Moon Park; Ki-Dong Yoo; Yu-Bae Ahn
Journal:  Diabetes Metab J       Date:  2013-08-14       Impact factor: 5.376

Review 4.  The clinical implications of recent studies on the structure and function of the retinal microvasculature in diabetes.

Authors:  Carol Yimlui Cheung; M Kamran Ikram; Ronald Klein; Tien Yin Wong
Journal:  Diabetologia       Date:  2015-02-11       Impact factor: 10.122

5.  Impairment of skin capillary recruitment precedes chronic complications in patients with type 1 diabetes.

Authors:  Eduardo Tibirica; Elba Rodrigues; Roberta Cobas; Marilia B Gomes
Journal:  Rev Diabet Stud       Date:  2007-08-10

6.  Emodin-6-O-β-D--glucoside inhibits high-glucose-induced vascular inflammation.

Authors:  Wonhwa Lee; Sae-Kwang Ku; Doohyun Lee; Taeho Lee; Jong-Sup Bae
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

7.  Orientin inhibits high glucose-induced vascular inflammation in vitro and in vivo.

Authors:  Sae-Kwang Ku; Soyoung Kwak; Jong-Sup Bae
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

Review 8.  Diabetic retinopathy in pregnancy.

Authors:  R M Best; U Chakravarthy
Journal:  Br J Ophthalmol       Date:  1997-03       Impact factor: 4.638

9.  Regulation of oxidative stress and cardioprotection in diabetes mellitus.

Authors:  Tetsuya Hayashi; Tatsuhiko Mori; Chika Yamashita; Masatoshi Miyamura
Journal:  Curr Cardiol Rev       Date:  2008-11

10.  Increased functional and structural skin capillary density in type 1 diabetes patients with vascular complications.

Authors:  Eduardo Tibiriçá; Elba Rodrigues; Roberta Cobas; Marilia B Gomes
Journal:  Diabetol Metab Syndr       Date:  2009-12-03       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.